All
5 FDA Solid Tumor Approvals from Spring 2024
The FDA has approved several treatments for patients with solid tumors. Here are five recently approved treatments.
What Cancer-Related Grief Felt Like to Me
After being diagnosed with cancer, I learned that everyone handles grief differently.
‘Seinfeld’ Actor Reveals Prostate Cancer Diagnosis, Ryne Sandberg Is Cancer-Free and More
From Michael Richards revealing his prostate cancer diagnosis to MLB Hall-of-Famer Ryne Sandberg being cancer-free, here’s what’s happening in the oncology space this week.
HPV Vaccines Associated With Lower Cancer Risk in Younger Adults
When compared with unvaccinated patients, HPV vaccines were associated with lower rates of HPV-related cancer for people younger than 40.
AI Navigation May Help Patients Schedule Missed Colonoscopies
An artificial intelligence-based navigation tool may be used to call patients who previously missed their colonoscopy appointment with the goal that they will reschedule and attend the new appointment.
Most Patients Attempting Pregnancy After Breast Cancer Succeed
In a group of breast cancer survivors, 73% who attempted pregnancy were successful, though there were certain characteristics associated with an increased chance of getting pregnant.
Knowing Benefits, Risks of Bladder-Conserving Therapies in Bladder Cancer
Bladder-conserving treatment may be beneficial for certain patients with non-muscle-invasive bladder cancer, and may not be for those with high-risk disease.
My Immunotherapy Journey During Lung Cancer
When I received my diagnosis of lung cancer, I didn't want to have chemotherapy, but the doctor knew best.
Lymph Node Radiation Reduced Death in Young Patients with Prostate Cancer
Whole-pelvic radiation conferred a 67% lower risk of all-cause mortality among patients younger than 65 with unfavorable-risk prostate cancer.
The Unexpected Joy of Cancer
My colon cancer diagnosis significantly dwarfed all my other problems.
MRD Status May Help Personalize Myeloma Treatment
Using tests to identify minimal residual disease may help determine how much treatment patients with multiple myeloma require.
FDA to Review Inavolisib Combo for HR-Positive, HER2-Negative Breast Cancer
The Food and Drug Administration granted a breakthrough therapy designation to inavolisib plus Ibrance and fulvestrant for HR-positive, HER2-negative locally advanced or metastatic breast cancer.
My Sister’s Cancer Anniversaries Are Days of Gratitude
My sister and I have learned to focus on the present day after a rollercoaster ride of remission, a cure and recurrence of stage 4 Hodgkin lymphoma.
Chemo for Breast Cancer May Lead to Declined Physical Function
Aerobic and strength training exercises may help preserve physical functioning in older adults with early-stage breast cancer who received chemotherapy.
A Poem About Cancer and Weeds
With my breast cancer experience, there's always a juxtaposition between the fear of mortality and the hope of living.
Onivyde May Have Similar Survival Outcomes as Chemo in Small Cell Lung Cancer
Onivyde did not outperform chemotherapy in improving outcomes for patients with relapsed small cell lung cancer, despite having better response rates.
Aricept Does Not Improve Chemo Brain, But Other Interventions Might
An Alzheimer’s drug did not have an effect on cognitive function in breast cancer survivors. However, one researcher noted reasons why there is still hope.
A Life Too Soon Taken by Metastatic Breast Cancer
When I received news of a fellow blogger’s demise, I was heartbroken.
Dato-DXd May Be Better Tolerated Than Chemo in HR+/HER2– Breast Cancer
Safety data further support datopotamab deruxtecan as a new treatment option in metastatic hormone receptor–positive, HER2-negative breast cancer.
Realizing How Precious Time is During Non-Hodgkin Lymphoma
Throughout my experience with stage 4 non-Hodgkin lymphoma, I realized that time is precious to me.
Chemo and IMRT Leads to Promising Outcomes in Vulvar Cancer
Most patients with locally advanced vulvar cancer who received chemotherapy and IMRT experienced a disappearance of their cancer.
SBRT and Hormone Therapy May Delay Advanced Prostate Cancer Progression
Stereotactic body radiotherapy and hormone treatment resulted in 40.1% 12-month progression-free survival in a recent study.
It’s OK to Dislike Your Body Because of Breast Cancer
My relationship with my body has changed over the years, especially during and after breast cancer. Now, I have accepted the way I look.
Surgery and Radiation May Have Similar Quality of Life Outcomes in Lung Cancer
Patients with high-risk early-stage non-small cell lung cancer who underwent surgery reported similar quality of life outcomes as those who had radiation.
Truqap/Faslodex Delays Time to Breast Cancer Progression, Next Therapy
Adding Truqap to Faslodex improved outcomes in patients with locally advanced or metastatic HR-positive, HER2-negative breast cancer.
A Poem: My Colon Cancer Remix
I hope my poem — which outlines my experience being diagnosed with colon cancer — brings light to someone’s day.
The Impact of the Oncology Nurse Navigator on the Lives of Patient and Caregiver
Jill May, B.S.N., RN, OCN, shows her commitment to her patients and their caregivers through acts of kindness and compassion — especially during tough times.
Checkmate: Beating Cancer at Its Own Game
One night, I had a dream that I played chess with Death and well, I won.
The Value of Time in Cancer Care
Dayna Hardee, RN, encourages patients, letting them know that someone has their back, someone is praying for them and someone is responding when they have a need.
Tecvayli Effective in BCMA-Pretreated R/R Multiple Myeloma
Tecvayli responses were found to be slightly lower in patients with relapsed/refractory myeloma treated with another BCMA-targeted therapy.